MedTrace Logo

Impact of Intrathecal Morphine on Sleep Apnea Syndrome

NCT02566226 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-11-04

No results posted yet for this study

Summary

Intrathecal morphine is commonly used as an analgesic adjunct for hip arthroplasty performed under spinal anaesthesia. Sleep apnea syndrome is a condition that affects up to 10% of the patients. Effect of intrathecal hydrophilic opioids on the frequency and duration of apneic episodes is unknown. The objective of this randomised controlled trial is to investigate the effect of intrathecal morphine and surgery on apneic episodes.

Conditions

  • Sleep Apnea Syndromes

Interventions

DRUG

Bupivacaine with normal saline

Isobaric bupivacaine 15 mg + normal saline 0.5 cc

DRUG

Bupivacaine with intrathecal morphine

Isobaric bupivacaine 15 mg + intrathecal morphine 100 mcg

Sponsors & Collaborators

  • Centre Hospitalier Universitaire Vaudois

    lead OTHER

Principal Investigators

  • Eric Albrecht, MD · University of Lausanne Hospitals

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2019-03-31
Completion
2019-03-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02566226 on ClinicalTrials.gov